BACKGROUND: Human embryonic stem (hES) cell lines were ®rst cultured using fetal mouse ®broblasts as feeder cells. To avoid feeders and to reduce the amount of xeno-components, Matrigel-and laminin-coated dishes, and conditioned mouse feeder cell medium have been used, and hES cells have also been cultured on human fetal muscle and skin, and adult Fallopian tube epithelial cells. METHODS: We used post-natal, commercially available human foreskin ®broblasts as feeder cells. Inner cell masses (ICM) were isolated from ®ve supernumerary blastocysts, obtained as donations from couples undergoing IVF treatment. RESULTS: Two ICM showed continuous growth. One line, HS181, has been in culture for 41 weeks with a doubling time of 24±36 h. It continues to express stem cell markers alkaline phosphatase, Oct-4, stage-speci®c embryonic antigen (SSEA)-4 and tumour-related antigen (TRA)-1-60. The karyotype is 46,XX. Pluripotency was demonstrated by teratoma formation in immunode®cient mice. In high-density cultures, spontaneous differentiation to beating cells and neuron-like cells was seen. The second line, HS207, was cultured for 9 weeks and cryopreserved, as were samples of line HS181. Both lines began to grow after thawing. CONCLUSIONS: We used successfully human foreskin ®broblasts as feeder cells for derivation and continued undifferentiated growth of hES cells. These feeder cells are convenient for IVF units, because no fetal human tissues or tissue from operations are needed.
Introduction
In-vitro culture of cells from human blastocysts was ®rst described in the early 1980s, and it was suggested that these cells might have potential in tissue repair (Fishel et al., 1984; Edwards, 2001; . Culture of cells from the inner cell mass (ICM) of human blastocysts and subsequent growth of embryonic stem (ES)-like cells for two passages with partial characterization was ®rst described by Bongso et al. (1994) . The concept of using human embryonic stem (hES) cells in transplantation received greater attention after the ®rst reports of permanent cell lines derived from human blastocysts showing pluripotent developmental capacity (Thomson et al., 1998; Reubinoff et al., 2000) .
On the basis of experience with mouse ES cells (Evans and Kaufman, 1981; Martin, 1981) these ®rst reported hES cell lines were cultured with mitotically inactivated fetal mouse ®broblast feeder cells, which also kept the human ES cells undifferentiated. In contrast to the situation with mouse ES cells (Smith, 1988) , leukaemia inhibitory factor (LIF) alone did not keep human ES cells undifferentiated (Thomson et al., 1998) . The use of mouse ®broblast feeder cells to a large extent inhibits the spontaneous differentiation of human ES cells in vitro and removal of the feeder cells leads to markedly enhanced differentiation (Reubinoff et al., 2000) . This development can be partially guided by adding growth factors to the medium (Schuldiner et al., 2000) .
The use of non-human materials bears a risk of transmitting pathogens, and they are not optimal in cultures aimed at cell transplantation in humans. Hence, cultures have been developed using extracellular matrix, Matrigel-or laminin-coated dishes and conditioned mouse feeder cell medium (Xu et al., 2001) . Successful culture of hES cells with human fetal muscle and skin cells and adult Fallopian tube epithelial cells as feeders has recently been described (Richards et al., 2002) .
With permission from the Ethics Committee of the Karolinska Institutet, we began to derive human embryonic stem cell lines from supernumerary blastocysts from our IVF unit. In the initial experiments, we used mouse embryo ®broblasts as feeder cells. Eleven cultures of ICM were kept proliferating for 10 days to 3 months before being cryopreserved. Six such ICM cultures were derived under conditions that ful®lled the criteria for stem cell registry at the National Institutes of Health (http://escr.nih.gov/).
In order to avoid using mouse feeder cells with human fetal cells, and to obtain a culture system which would be simple and feasible for IVF units, we developed the use of post-natal human ®broblasts, which have been used earlier as substrate cells for several cell types (Muggleton-Harris and Aroian, 1982; Muggleton-Harris and Findlay, 1991) , in our derivation and culture of human ES cells.
Materials and methods
For this project, we received ®ve donated blastocysts from consenting couples. Only one of the blastocysts had expanded by day 6, and all had only a few cells in the ICM. The donating couples had good quality embryos for transfer and cryopreservation, and the donated blastocysts would have been discarded if not used in research. The embryos had been cultured in IVF medium (Vitrolife, Sweden) individually in 20 ml droplets under oil for the ®rst 2 days, and then transferred to blastocyst medium (CCM, Vitrolife). They were transferred to the research laboratory on day 6 after fertilization. For evaluating the quality of the blastocysts, the scoring system described by Gardner et al. (1998) was used.
Isolation of the ICM was carried out by ®rst removing the zona pellucida using 0.5% Pronase (Sigma, USA). The trophectoderm was removed by immunosurgery as described earlier (Solter and Knowles, 1975) , using rabbit antihuman whole serum (Sigma) and guinea-pig complement serum (Sigma).
As substrate cells, we decided to use commercially available human foreskin ®broblasts (CRL-2429; ATCC Mananas, USA). The ®broblasts, with an anticipated life span of 61 doublings, were used in our experiments after 9±25 doublings. The cells were grown to form a con¯uent monolayer, and irradiated (35 Gy) before being used as substrate cells. The medium used in culture of these feeder cells was Iscovs medium (GibcoBRL, Life Technologies, Sweden) supplemented (10%) with fetal calf serum (FCS; SDS, Sweden).
The ICM were transferred to culture dishes containing the feeder cells. The dishes used were plastic dishes tested for use in embryo culture (Falcon; Becton Dickinson, USA). The culture medium used for derivation and culture of the hES cells was Knockout D-MEM 1Q (GibcoBRL, Life Technologies), supplemented with 2 nmol/l L-glutamine, 20% FCS (R&D, Sweden), 0.1 mmol/l b-mercaptoethanol (Gibco), 1% non-essential amino acids (Gibco), and recombinant human LIF, 1 ml/ml (Chemicon, UK). The FCS batch used in these experiments had been selected from a large number of tested batches based on the criteria of strong proliferation and induction of a minimum amount of differentiation, in two different mouse ES cell lines (D3 and GS-1). The same selection criteria are routinely used for selection of FCS for mouse ES cell cultures in our core facility for the generation of knock-out mice.
After an initial growth period of 9±19 days, the cell aggregates were removed from the dish by using a mild dispase solution (10 mg/ml; Gibco BRL, Life Technologies) and mechanical slicing using glass capillaries. The cell aggregates were transferred to new plates containing similar feeder cells. After the ®rst splitting, the new growing aggregates were again split and transferred to new dishes every 5 days. Undifferentiated cells, as judged by morphology, were chosen for each further passage.
For freezing of the cells, vitri®cation in pulled open straws, using ethylene glycol, dimethylsulphoxide (20% each) and 1 mol/l sucrose as cryoprotectants, was carried out as described by Reubinoff et al. (2001) .
The growing cells were characterized immunohistochemically by using antibodies against markers characteristic of non-differentiated ES cells. The antibody for Oct-4 was a kind gift from Dr G.A.Schulz (University of Calgary, Canada), that for TRA-1-60 was a kind gift from Dr P.Andrews (University of Shef®eld, UK), and the antibody for SSEA-4 was from the Developmental Studies Hybridoma Bank, University of Iowa, USA. The expression of alkaline phosphatase was shown by using a Vector Blue/Red substrate kit (Vector Laboratories, USA). The cells were ®xed with 4% paraformaldehyde. Fluorescent secondary antibodies, Cy3 (Jackson Immuno Research, USA) or AlexaFluor 488 (Molecular Probes Inc., USA) were used. P19 and TERA-2 cell lines and human foreskin ®broblasts were used as controls. Non-immune serum was also used as a negative control for the human ES cell line in question. The karyotype was determined by standard G-banding.To test pluripotency,~10 3 cells at passage 20 were injected to the right testis of SCID-beige mice (C.B.-17/ GbmsTac-scid-bgDF N7 from M&B, Denmark). The teratoma formation was followed up by palpation and the resulting tumours were ®xed, embedded in paraf®n and processed for histology.
Results
One of the donated blastocysts, scoring 2BA (not expanded, small number of cells in the ICM but a good number of cells in the trophectoderm) did not grow at all. Two ICM, from blastocysts scoring 2BB (not expanded, small numbers of cells in the ICM and trophectoderm) and 3BB (large blastocoele, but not fully expanded, small numbers of cells in the ICM and trophectoderm) survived on the feeders for 1 and 4 weeks respectively. From two blastocysts we obtained cell lines. The line HS181 was derived from a blastocyst scoring 4BB (expanded, small cell numbers in the ICM and trophectoderm). The line HS207 was obtained from a blastocyst with a score of 2CB (not expanded, hardly any visible ICM, few cells in the trophectoderm). The outgrowth of cells from these two blastocysts was seen within 1 week after initial plating on the substrate cells.
The ®rst line, HS181, has been in continuous culture for 41 weeks, with a doubling time of~24±36 h (Figure 1 ). This line has been enzymatically and mechanically split and transferred to new dishes by the time the aggregate has been formed bỹ 2.5±6.4Q10 3 cells. The size of the transferred aggregates has been~1±2Q10 3 cells. Spontaneous differentiation was observed in 10±20% of the cells, in one out of 20 colonies during the 5 day culture period. High-density cultures regularly showed spontaneous development into multinuclear aggregates containing both undifferentiated and differentiated cells, including neural tube-like cells and structures, and beating cells. After 9 months, the cells (80±100% of the cells in each aggregate) continue to express alkaline phosphatase, Oct-4, SSEA-4 and TRA-1±60 ( Figure 2A±G . The karyotype is 46,XX, with no structural aberrations (Figure 3) .
Teratoma formation showing pluripotency of the 181 cells was obtained after injection of passage 20 of these cells to the testes of SCID mice. The teratomas were analysed 18 weeks after the injection. They contained macroscopically well circumscribed tumour-like structures, containing cystic cavities and solid areas. Some of the cysts were ®lled with a gelatinous substance. In Figure 4A , tissue with endodermal differentiation is shown. There is a cavity lined by cylindrical cells with basally located nuclei, and numerous lightly stained goblet cells. Below these structures, there are tissue components showing mesodermal differentiation; connective tissue stroma and cells with spindle form with elongated nuclei, which are typical of smooth muscle layer of the intestine. Differentiation to ectoderm is demonstrated in Figure 4B . Multi-layered nuclei are arranged in rows compatible with formation of neural epithelium or neural rosettes. Differentiation into cartilage is demonstrated in Figure 4C .
The second line (HS207) was not characterized, but it was morphologically similar to the line HS181. Hence, we do not have evidence from the possible pluripotency of this line. It was cultured for 9 weeks and then cryopreserved, as were samples of line HS181. Both of the cell lines have been thawed, and have undergone divisions, showing that these cells survive freezing and thawing.
Discussion
Our results with the human ES cell lines show that post-natal human feeder cells, in this case foreskin ®broblasts, support the derivation of new hES cell lines, and continued undifferentiated growth of these cells. The hES cells were cultured on commercially available human foreskin ®broblasts, which makes the procedure simple and accessible to IVF laboratories starting to derive human ES cells for cell banks. In their recent article, Richards et al. (2002) reported successful culture of human ES cells on human fetal muscle and fetal skin cells and human adult tubal epithelial cells. Our approach, involving human skin ®broblast cells, is an even simpler solution, because no fetal material after termination of pregnancy or tissue from gynaecological operations is needed.
For IVF units working without animal facilities, the use of human cells is more convenient than the use of mouse cells as feeders. In addition, the quality control systems of most of the IVF units do not allow culture of mouse cells in the same facility.
Finding optimal techniques to culture human ES cells without a feeder layer, and culturing them without FCS, is important for cell transplantation. Xu et al. (2001) have already been successful with non-feeder cultures, but the conditioned medium from mouse cell cultures is not optimal as regards human transplantation. The risk of transmitting pathogens still exists when conditioned medium from mouse ®broblast cultures is used. In the present study we used FCS in the cultures, and the next step is to replace it with human serum, and ®nd serum-free conditions with synthetic serum supplements. The use of human serum has already been successful when using other feeder cells (Richards et al., 2002) . Optimally, also the feeder cells should also be cultured in serum-free medium, which has been tested (Amit et al., 2000) . The serum-free system is hence already well established for the culture of human ES cells. On the other hand, FCS has been accepted as an ingredient of culture media for transplantable adult stem cells. To obtain transplantable cells, good manufacturing practice (GMP) conditions are needed, and at our hospital such a facility is being built.
The hES cell characteristics of the line 181 cells were supported by the expression of the surface markers, Oct-4, SSEA-4 and Tra-1-60. In addition, after injection of the 181 cells into immunode®cient mice, teratomas containing tissue components consistent with all the three embryonic layers were found in the recipient mice, as a sign of pluripotency.
Also when cultured at high density, spontaneous differentiation occurred.
We added rLIF to the cultures in spite of earlier reports that it does not support the growth of human ES cells without feeders (Thomson et al., 1998) .
We could not obtain any really good quality blastocysts for our stem cell cultures, because all such embryos are either Culture of human embryonic stem cells transferred to the subject or frozen for the couple's infertility treatment in the future. None of our blastocysts had a good cell number in the ICM. Nevertheless, we obtained cell lines from ICM with low numbers of cells. The line HS207 was actually derived from a blastocyst with very few cells in the ICM, although it did not grow as well as the line HS181, and its pluripotency has not been veri®ed. Nevertheless, this is encouraging when thinking of an hES cell bank with a large enough number of different genotypes for cell transplantation in the future. Creating good quality embryos for research might be an excellent option, but it bears ethical problems (McLaren, 2001 ), which may be avoided by using supernumerary lowquality embryos.
We intend to use this method to establish new ES cell lines for the new cell bank supported by the Swedish Medical Research Council and Juvenile Diabetes Research Foundation, to provide cells for academic collaborators. Ro Èdin are thanked for help in karyotyping, and Nicholas Bolton for revising the language. The project was supported by grants from Huddinge University Hospital, the Michael J.Fox Foundation and the Karolinska Institute, and the Swedish Medical Research Council.
